LFMD Q1 2023 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena

LFMDLifeMD, Inc.

$182M

Q1 2023 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$33M+14.1% YoY

Gross Profit

$29M87.3% margin

Operating Income

-$3M-8.6% margin

Net Income

-$4M-12.1% margin

EPS (Diluted)

$-0.32

QoQ Revenue Growth

+17.8%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$4M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$34M

Total Liabilities

$41M

Stockholders' Equity

-$7M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$33M	$29M	+14.1%
Gross Profit	$29M	$24M	+21.5%
Operating Income	-$3M	-$13M	+78.2%
Net Income	-$4M	-$13M	+69.9%